IMPRIMED
IMPRIMED
Industry:
Biotechnology Health Care Medical Veterinary
Founded:
2017-05-04
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.imprimedicine.com
Total Employee:
11+
Status:
Active
Total Funding:
11.73 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Content Delivery Network Apache JsDelivr AJAX Libraries API BootstrapCDN Apache 2.4
Similar Organizations
Disc Medicine
Disc Medicine is a hematology company
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Endpoint Health
Precision Immunology Therapies
epiclinic
cosmetic medicine, health & beauty
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Pinpoint Pharma
Custom medicine for pets on demand
Praxis Precision Medicines
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Protean BioDiganostics Inc
Precision Oncology and Diagnostics
Scailyte
True precision medicine through single-cell science
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Advisors List
Board_member
2017-01-01
Current Employees Featured
Sungwon Lim CEO & Co-Founder @ ImpriMed
CEO & Co-Founder
2017-05-01
Founder
Investors List
Mayo Clinic Platform
Mayo Clinic Platform investment in Seed Round - ImpriMed
Murex Partners
Murex Partners investment in Seed Round - ImpriMed
FuturePlay
FuturePlay investment in Seed Round - ImpriMed
HG Initiative
HG Initiative investment in Seed Round - ImpriMed
ES Investor
ES Investor investment in Seed Round - ImpriMed
Primer Sazze Partners
Primer Sazze Partners investment in Seed Round - ImpriMed
Draper Associates
Draper Associates investment in Seed Round - ImpriMed
Draper Dragon
Draper Dragon investment in Seed Round - ImpriMed
Translink Investment
Translink Investment investment in Seed Round - ImpriMed
Bon Angels Venture Partners
Bon Angels Venture Partners investment in Seed Round - ImpriMed
Official Site Inspections
http://www.imprimedicine.com Semrush global rank: 1.8 M Semrush visits lastest month: 12.73 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
Imprimedicine.com lookup results from whois.squarespace.domains server:
- Domain created: 30th-Jan-2016
- Domain updated: 15th-Jan-2025
- Domain expires: 30th-Jan-2026 0 Years, 288 Days left
- Website age: 9 Years, 77 Days
- Registrar Domain ID: 1998670667_DOMAIN_COM-VRSN
- Registrar Url: http://domains2.squarespace.com
- Registrar WHOIS Server: whois.squarespace.domains
- Registrar Abuse Contact Email: abuse-complaints@squarespace.com
- Registrar Abuse Contact Phone: +1.6466935324
- Name server:
- NS-1150.AWSDNS-15.ORG
- NS-2002.AWSDNS-58.CO.UK
- NS-410.AWSDNS-51.COM
- NS-995.AWSDNS-60.NET
More informations about "ImpriMed"
About Us - ImpriMed
ImpriMed's mission to empower clinicians and help patients with the best predictive information for personalized cancer careSee details»
ImpriMedicine
At ImpriMed, we understand how overwhelming it can be when your furry friend is diagnosed with lymphoma. That's why we offer advanced testing to help identify the most effective …See details»
ImpriMed - Crunchbase Company Profile & Funding
ImpriMed is a company that creates individualized drug response prediction technology to help veterinarians fight lymphoma. The company's technology …See details»
Human Oncology - ImpriMed
We first launched the ImpriMed platform in the veterinary oncology space which moves at a significantly higher speed than the human oncology market and allows easy access to comprehensive patient data. ImpriMed has helped 200+ …See details»
ImpriMedicine
New user? Create an accountEmailImpriMedicineSee details»
ImpriMed: Fighting Cancer — From Dogs To Humans
Apr 6, 2021 ImpriMed is a biotech startup that innovates the way of cancer care based on science and medicine. Our mission is to help oncologists provide more tailored treatment approaches; based on data ...See details»
ImpriMed - Company Profile - Tracxn
Jan 18, 2025 ImpriMed - Provider of precision medicines for veterinary cancer. Raised a total funding of $34.9M over 5 rounds from 28 investors.See details»
ImpriMed Raises $23 Million Series A Round to Expand …
Dec 19, 2023 Series A round led by SBVA (SoftBank Ventures Asia) to help expand ImpriMed’s services beyond veterinary medicine into human oncologySee details»
ImpriMed - YouTube
Our mission here at ImpriMed is to provide oncologists with the tools they need to make more informed decisions about their patients’ cancer care. In the process, we hope to be able to …See details»
ImpriMed Unveils Cancer Treatment Prediction Technology at EHA …
Sep 23, 2024 The company also plans to broaden its contract research organization (CRO) services, offering pharmaceutical companies access to ImpriMed’s cutting-edge live-cell …See details»
Expert Oncology Services | Advanced Cancer Care …
ImpriMed is bringing together our expertise in humans and canines to accelerate the development of AI-driven solutions for all cancer patients.See details»
ImpriMedicine - Identifying personalized drug combinations
What we do Our product is a highly scalable, high-throughput drug-sensitivity assay kit for precision medicine ApplicationsSee details»
ImpriMedicine
Note: The email above will be used for sign in and all communications from the team at ImpriMed.ImpriMedicineSee details»
ImpriMed - Pet Care Innovation
ImpriMed helps veterinary oncologists personalize chemotherapy by providing a data-driven drug response prediction for individual cancer patients.See details»
Participate in Our Research - ImpriMedicine
Join us in our continuous research and development efforts to drive innovations in the field of veterinary oncology. Together, we can enhance cancer care and make a meaningful impact.See details»
ImpriMed Unveils Cancer Treatment Prediction Technology at
Sep 23, 2024 With our expansion into contract research organization services, we look forward to supporting the development of novel cancer therapies and more personalized treatments, …See details»
PowerPoint Presentation
Learn more at www.imprimedicine.com Sungwon Lim, Ph.D. ImpriMed, Inc. sungwon@imprimedicine.com We are looking for ... Partners Pharma companies Clinical trial …See details»
Terms of Service - ImpriMed
Jan 11, 2021 Our failure to insist upon or enforce strict performance of any provision of these Terms shall not be construed as a waiver of any right. Notices We may notify you via postings …See details»
Imprimedicine - GitHub
People This organization has no public members. You must be a member to see who’s a part of this organization.GitHub is where Imprimedicine builds software.See details»
Vet Portal | Streamlined Veterinary Lab Services Online
ImpriMed Vet Portal is a sample and test result management system that enables veterinarians to easily request our service, track progress, and access test results.See details»